/VRBCF
VRBCF Stock - Virbac S.A.
Healthcare|Drug Manufacturers - GeneralOTC
$346.00+0.00%
+$0.00 (+0.00%) • Dec 19
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.52
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.83
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $380.60
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VRBCF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$342.54 – $349.46
TARGET (TP)$397.90
STOP LOSS$318.32
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.92
52W High$431.80
52W Low$324.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.40B | $1.25B | $1.22B | $1.06B | $934.20M |
| Gross Profit | $937.60M | $809.60M | $794.99M | $712.85M | $617.56M |
| Gross Margin | 67.1% | 64.9% | 65.4% | 67.0% | 66.1% |
| Operating Income | $227.50M | $184.88M | $179.52M | $167.63M | $183.75M |
| Net Income | $145.29M | $121.30M | $121.97M | $113.16M | $136.04M |
| Net Margin | 10.4% | 9.7% | 10.0% | 10.6% | 14.6% |
| EPS | $17.35 | $14.38 | $14.44 | $13.40 | $16.12 |
Company Overview
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
VRBCFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$11.58
Q3 2025
EPS Surprise History
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q1 24
No data
Q4 24
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2026 | Sep 10, 2026 | — | — | — | — |
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q3 2025 | Sep 12, 2025 | — | $11.58 | — | — |
Q2 2025 | May 13, 2025 | — | $6.26 | — | — |
Q4 2024 | Oct 17, 2024 | — | $12.14 | — | — |
Q1 2024 | Mar 20, 2024 | — | $6.04 | — | — |
Q2 2023 | Jun 30, 2023 | — | $9.68 | — | — |
Q4 2022 | Dec 31, 2022 | — | $5.66 | — | — |
Q2 2022 | Jun 30, 2022 | — | $9.59 | — | — |
Q4 2021 | Dec 31, 2021 | — | $5.42 | — | — |
Q2 2021 | Jun 30, 2021 | — | $10.22 | — | — |
Q4 2020 | Dec 31, 2020 | — | $13.13 | — | — |
Q2 2020 | Jun 30, 2020 | — | $6.29 | — | — |
Q4 2019 | Dec 31, 2019 | — | $3.38 | — | — |
Q2 2019 | Jun 30, 2019 | — | $3.56 | — | — |
Q4 2018 | Dec 31, 2018 | — | $1.11 | — | — |
Q2 2018 | Jun 30, 2018 | — | $1.69 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-2.30 | — | — |
Q2 2017 | Jun 30, 2017 | — | $1.88 | — | — |
Q4 2016 | Dec 31, 2016 | — | $2.68 | — | — |
Latest News
Loading news...
Frequently Asked Questions about VRBCF
What is VRBCF's current stock price?
Virbac S.A. (VRBCF) is currently trading at $346.00 per share. The stock has moved +0.00% today.
What is the analyst price target for VRBCF?
No analyst price targets are currently available for this stock.
What sector is Virbac S.A. in?
Virbac S.A. operates in the Healthcare sector, specifically within the Drug Manufacturers - General industry. The company is traded on the OTC exchange.
What is VRBCF's market cap?
Virbac S.A. has a market capitalization of $2.90 billion, making it a mid-cap company.
Does VRBCF pay dividends?
No, Virbac S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAPNHF
Aspen Pharmacare Holdings Limited
$6.23
Mkt Cap: $2.8B
BVNKF
Bavarian Nordic A/S
$30.65
Mkt Cap: $2.4B
BVNRY
Bavarian Nordic A/S
$9.85
Mkt Cap: $2.3B
GGNDF
GN Store Nord A/S
$16.62
Mkt Cap: $2.4B
GNNDY
GN Store Nord A/S
$48.82
Mkt Cap: $2.4B
HAWPF
Haw Par Corporation Limited
$10.66
Mkt Cap: $2.4B
HAWPY
Haw Par Corporation Limited
$50.80
Mkt Cap: $2.8B
HYPMY
Hypera S.A.
$4.40
Mkt Cap: $2.8B
PTKFF
PT Kalbe Farma Tbk.
$0.07
Mkt Cap: $3.3B
SNPHY
Santen Pharmaceutical Co., Ltd.
$10.37
Mkt Cap: $3.5B
Explore stocks similar to VRBCF for comparison